Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.

about

Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.

Item

http://www.wikidata.org/entity/Q48175785

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Solid Lipid Nanoparticles Carr ...... In Vitro and In Vivo Studies.

@en

Solid Lipid Nanoparticles Carr ...... In Vitro and In Vivo Studies.

@nl

type

Item

label

Solid Lipid Nanoparticles Carr ...... In Vitro and In Vivo Studies.

@en

Solid Lipid Nanoparticles Carr ...... In Vitro and In Vivo Studies.

@nl

prefLabel

Solid Lipid Nanoparticles Carr ...... In Vitro and In Vivo Studies.

@en

Solid Lipid Nanoparticles Carr ...... In Vitro and In Vivo Studies.

@nl

P1476

Solid Lipid Nanoparticles Carr ...... In Vitro and In Vivo Studies.

@en

P2093

Benedetta Ferrara

http://www.w3.org/2001/XMLSchema#string

Davide Schiffer

http://www.w3.org/2001/XMLSchema#string

Elena Biasibetti

http://www.w3.org/2001/XMLSchema#string

Elisabetta Muntoni

http://www.w3.org/2001/XMLSchema#string

Laura Annovazzi

http://www.w3.org/2001/XMLSchema#string

Luigi Cangemi

http://www.w3.org/2001/XMLSchema#string

Marta Mellai

http://www.w3.org/2001/XMLSchema#string

Umberto Dianzani

http://www.w3.org/2001/XMLSchema#string

P2860

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma.

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).

Inhibition of angiogenesis by non-toxic doses of temozolomide.

Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA.

Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo.

P31

scholarly article

P356

10.3390/IJMS19020255

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chiara Dianzani

Nausicaa Clemente

Casimiro Luca Gigliotti

Elena Boggio

Luigi Battaglia

Gianluca Miglio

Maria Teresa Capucchio

P577

2018-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29364157

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

P932

5855544

http://www.w3.org/2001/XMLSchema#string